Pulmonary delivery of liposomal-encapsulated cannabinoids

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/352 (2006.01) A61K 9/127 (2006.01) A61K 31/05 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2341035

A liposomal composition containing a cannabinoid or cannabimimetic agent and methods of systemic delivery by contacting pulmonary tissue of a mammal with the liposomal composition to achieve a prolonged psychoactive effect.

L'invention concerne une composition liposomale contenant un agent cannabinoïde ou cannabimimétique. L'invention concerne également des méthodes d'administration systémique, par contact du tissu pulmonaire d'un mammifère avec la composition liposomale, afin d'obtenir un effet psychoactif prolongé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pulmonary delivery of liposomal-encapsulated cannabinoids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pulmonary delivery of liposomal-encapsulated cannabinoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary delivery of liposomal-encapsulated cannabinoids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1678766

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.